| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Citric acid preparation |
Is a |
False |
Citric acid |
Inferred relationship |
Some |
|
| Product containing citric acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| kaliumhydrogenkarbonat 1,39 g + citronsyre 1,14 g opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Citric acid + potassium bicarbonate 2ns/2.5ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyre + monohydrat + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyre 640 mg + natriumcitrat 490 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + natriumcitratdihydrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Sodium citrate and citric acid |
Is a |
False |
Citric acid |
Inferred relationship |
Some |
|
| Product containing citric acid and potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing citric acid and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing citric acid and ipecacuanha (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| opløsning G, skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| opløsning R, skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyre 33,01 g/magnesiumkarbonat 15,885 g/gluconolacton 0,99 g skyllevæske, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citronsyre + magnesiumkarbonat + gluconolacton |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citric acid |
Inferred relationship |
Some |
3 |
| Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid- and magnesium oxide- and sodium picosulfate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid monohydrate (substance) |
Is a |
False |
Citric acid |
Inferred relationship |
Some |
|
| Product containing citric acid and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Citrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Citrate monohydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Methylcitrat |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| citratsalt |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| 2-methylcitrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Disodium citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Citric acid |
Inferred relationship |
Some |
|
| Product containing citric acid and nalidixic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Citric acid monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citric acid |
Inferred relationship |
Some |
|
| Allergy to citric acid (finding) |
Causative agent |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Gallium (67-Ga) citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citric acid |
Inferred relationship |
Some |
|
| Erbium (169-Er) citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citric acid |
Inferred relationship |
Some |
|
| Citric acid and magnesium oxide and sodium picosulfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Citric acid and gluconic acid and magnesium carbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid and ipecacuanha only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Citric acid and magnesium carbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing only citric acid and nalidixic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing only citric acid and potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing only citric acid and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
2 |
| Product containing only citric acid and magnesium oxide and sodium picosulfate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid and potassium bicarbonate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Product containing citric acid and potassium citrate and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid- and potassium citrate- and sodium citrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Product containing citric acid and potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Product containing only citric acid and potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Product containing citric acid and potassium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
1 |
| Citric acid and potassium citrate and sodium citrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid and potassium citrate and sodium citrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Product containing citric acid and gluconic acid and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citric acid |
Inferred relationship |
Some |
3 |
| Citric acid anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citric acid |
Inferred relationship |
Some |
|
FHIR